相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia
Maria Donata Di Taranto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Homozygous familial hypercholesterolemia: what treatments are on the horizon?
Archna Bajaj et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Cholesterol-Lowering Agents PCSK9 Inhibitors Today and Tomorrow
Robert S. Rosenson et al.
CIRCULATION RESEARCH (2019)
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study
Claudia Stefanutti et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017
Alison Pottle et al.
ATHEROSCLEROSIS (2019)
Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
Gilbert R. Thompson et al.
EUROPEAN HEART JOURNAL (2018)
Autosomal Recessive Hypercholesterolemia Long-Term Cardiovascular Outcomes
Laura D'Erasmo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort
Sophie Beliard et al.
ATHEROSCLEROSIS (2018)
Familial hypercholesterolemia treatments: Guidelines and new therapies
Frederick J. Raal et al.
ATHEROSCLEROSIS (2018)
Lomitapide for the treatment of hypercholesterolemia
Amanda J. Berberich et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia
Antonio Gallo et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
Frederick J. Raal et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy
Laura D'Erasmo et al.
ADVANCES IN THERAPY (2017)
Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France
Eric Bruckert et al.
ATHEROSCLEROSIS (2017)
The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients
Sophie Beliard et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
Rodrigo Alonso et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
P. Barton Duell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
Alpo Vuorio et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
Frederick J. Raal et al.
CIRCULATION (2011)
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
Gilbert R. Thompson et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia
Daniel M. Kolansky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
A systematic review of LDL apheresis in the treatment of cardiovascular disease
Jeff Thompsen et al.
ATHEROSCLEROSIS (2006)
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
AA Kroon et al.
ATHEROSCLEROSIS (2000)
分享论文
